INTRODUCTION
The complement system plays an important role in the immune defence against infection. It consists of a group of plasma and membrane proteins that, when activated by immune complexes and foreign materials, interacts in cascade fashion to accelerate the elimination of foreign materials from the body (Lachmann and Hughes-Jones, 1985; Miiller-Eberhard, 1988) . These effector functions of the complement system are mediated by a serine proteinase, C3 convertase, which is generated via two independent cascades, termed the classical and alternative pathways. The C3 convertase of the classical pathway is assembled from two complement components, C4 and C2, by the action of CTs (Vogt et Maeda and Nagasawa, 1990) .
C4 consists of three non-identical disulphide-linked chains designated a,,/ and y, having molecular masses of 93, 78 and 33 kDa respectively (Schreiber & Miiller-Eberhard, 1974) . The cleavage of the a chain by Cls produced a low-molecular-mass activation peptide, C4a and a major cleavage fragment, C4b (Schreiber & Miiller-Eberhard, 1974) . The cleavage reaction is accompanied by the generation of at least three binding sites, i.e. one labile and two stable binding sites on the nascent C4b. The labile binding site is the site through which a nascent C4b binds covalently on immune complexes (Gorski and Howard, 1980; Law et al., 1981) . The stable binding sites are the sites for C2 and C4bp, these two components being respectively involved in the assembly and regulation of the classical-pathway C3 convertase; C4b-C2 complex is cleaved by Cls to assemble C3 convertase, C4b2a (Muiller-Eberhard et al., 1967; Kerr, 1980) , whereas the sine residues are involved in the epitope. There is a single lysine residue at 1259 in the 13 kDa C-terminal side of C4d and the synthetic undecapeptide Leu'254-Asp'264 was found to inhibit the binding of C4 to mAb Al 121/6, suggesting that the epitope for mAb Al 121/6 is involved in the sequence. The N-terminal portion of the peptide is partly overlapping, with a highly hydrophobic amino acid sequence spanning residues Ala'249-Leu-LeuHis-Leu-Leu-Leu'255. The surface hydrophobicity of C4 has been reported to decrease upon treatment with Cls and methylamine. So it appears that the hydrophobic sequence spanning Ala'249-Leu'255 may be hidden, together with the linear epitope, into the inner region of C4 upon treatment with Cls and methylamine.
C4b-C4bp complex is cleaved by Factor I into functionally inactive C4c and C4d (Gigli et al., 1979; Nagasawa et al., 1980) . Although the labile binding site has been proved to be Gln994, forming an internal thioester linkage with a Cys991 (Campbell et al., 1981; Harrison et al., 1981) , the sequence and location of the stable binding sites have not yet been determined.
These binding sites in C4b are generated by a series of conformational changes triggered by the limited proteolysis of C4. It was reported that C4 activation with CTs was accompanied by decrease in the surface hydrophobicity and alteration of backbone conformation (Isenman & Kells, 1982) . In addition, inactive C4 having the similar conformation to C4b is known to be produced upon treatment with methylamine (Isenman & Kells, 1982) . However, it has not been shown clearly which portions in a C4 molecule are conformationally labile.
Monoclonal antibodies (mAbs) which recognize neoantigenic epitopes expressed in activated complement components have shown to be effective as probes to investigate the molecular changes associated with the activation of complement components (Nilsson & Nilsson, 1982; Lambris et al., 1985; Becherer et al., 1992) . We have reported an mAb, mAb242, which recognizes a conformation-dependent neoantigen generated in C4b and inhibits the binding of C2 and C4bp to C4b (Ichihara et al., 1986 (Nagasawa et al., 1980) , CTs (Takahashi et al., 1975) , Factor I (Nagasawa et al., 1980) and C4bp (Nagasawa et al., 1982) were purified from human plasma by the methods cited. Methylamine-treated C4 was prepared by treatment with 1 M methylamine hydrochloride at 37°C for 60 min (Isenman and Kells, 1982) and dialysed against 20 mM Tris/HCl, pH 7.4. C4c and C4d were produced by cleavage of C4b with C4bp and Factor I (Nagasawa et al., 1980) and purified by size-exclusion h.p.l.c. The synthetic undecapeptide Leu-LeuHis-Glu-Lys-Ala-Glu-Met-Ala-Asp was prepared by using an Applied Biosystem 430A synthesizer by the standard solid-phase procedure of Merrifield (1963 . (1979) . The immunoreactivity of the mAb with the transferred polypeptide chains was tested using a 1: 2000 dilution of peroxidase-conjugated IgG fraction of goat anti-mouse IgG (TAGO) as the second antibody and diaminobenzidine reagent for the detection of the binding of peroxidase-conjugated antibody.
Haemolytic assay
The effect of the mAb to the haemolytic activity of human serum was determined with sheep erythrocytes sensitized with IgM antibody (EA), which were prepared according to standard techniques (Mayer, 1961 (Janatova & Tack, 1981 (Figure 3) . Thus it appears likely that the epitope for mAb Al 121/6 is located at the surface of C4 molecule and shifted into the inner portion by a series of conformational changes when the thioester bond is cleaved upon enzymic or chemical treatment of
C4.
To ascertain whether the hidden epitope for mAb Al 121/6 might be exposed again in C4d, mAb Al 121/6 and C4d were mixed and subjected to size-exclusion h.p.l.c. As shown in Figure  4 , C4d formed a high-molecular-mass immune complex with mAb Al 121/6.
Effect of mAb Al 121/6 on the functions of C4
We examined whether the epitope for mAb Al 121/6 is responsible for the functions of C4. First, the C4-mAb complex was isolated by h.p.l.c. using Superose 6 and allowed to react with Cis. SDS/PAGE of the reduced sample revealed that the achain (93 kDa) was cleaved to give an ax'-chain (87 kDa), indicating that binding of mAb Al 121/6 to C4 does not inhibit the Cls-catalysed a-chain cleavage ( Figure 5 ). This result also suggests that the epitope for mAb Al 121/6 is located far from the Cls-susceptible bond Arg737-Ala738 in the a-chain of C4. Next we tested the effect of mAb Al 121/6 on the haemolytic activity of C4. Figure 6 shows the effects of mAb Al 121/6 and mAb 242 on the haemolysis of EA cells by human serum. As reported previously (Ichihara et al., 1986) , mAb 242, whose epitope is closely related with the C2-binding site in C4b, inhibited the haemolytic activity of human serum, but mAb Al 121/6 did not inhibit the haemolysis of EA cells by human serum. Production of the epitope-containing fragments by trypsin digestion of C4d
To characterize the location of the epitope for mAb Al 121/6 in C4d we attempted to prepare an epitope-containing fragment by trypsin digestion of C4d. SDS/PAGE and Coomassie Blue staining of trypsin digest of C4d showed that C4d (48 kDa) was first cleaved into a 41 kDa fragment and subsequently into a 28 kDa fragment (Figure 7) . Western-blot analysis showed that the epitope for mAb Al 121/6 remained in the 41 fragment. The two C4d fragments were isolated from each other by SDS/PAGE of the trypsin-treated C4d and subjected to Nterminal amino-acid-sequence analysis. The N-terminal sequences of the two C4d fragments were found to be identical (Val-Thr-Ala-Ser-Asp-Pro-Leu-Asp) and were identified as representing amino acid residues 24-31 of C4d sequence, i.e. residues 961-968 of the C4 sequence (Belt et al., 1984) . This result indicated that the 28 kDa C4d fragment is derived from the Figure 7 SDS/PAGE and Western-blot analysis of trypsin-treated C4d
C4d was digested with trypsin at a C4d/enzyme weight ratio of 50:1 for 0 (1), 0.5 (2), 1 (3), 2 (4), 5 (5), and 16 (6) Leu-His-Glu-Gly-Lysl259-Ala-Glu-Met-Ala-Asp. After is different from the corresponding region of mouse C4 in the three residues His1256, Ala1260, and Glu1261 (Nonaka et al., 1985) . These residues may act as the antigenic determinants for the production of mAb Al 121/6. Evidence that mAb Al 121/6 fails to inhibit the functional activities of C4 suggests that the epitope region neither constitutes the functional sites of activated C4b nor locates in the vicinity of the functional sites. Interestingly enough, the N-terminal portion of this epitope is a part of long hydrophobic region such as Ala1249-Leu-Leu-His-Leu-Leu-Leu 255. It is well known that the surface hydrophobicity of C4 decreases upon activation/ inactivation of C4 (Isenman and Kells, 1982) , so it seems probable that a long region spanning residues Ala1249-Asp1264 is hidden from the surface upon activation/inactivation of C4. This conformational change appears to be triggered by the split of an internal thioester linkage, which is located at approx. 100 amino acids on the N-terminal side of the epitope. There are two functionally related regions between the thioester linkage and the epitope region. One is the region comprising residues 1108-1115, which defines the specificity of surface binding of nascent C4b (Carroll et al., 1990) . The other is the Ser12 7, which is the acceptor site for a nascent C3b in the conversion of the C3 convertase into the C5 convertase, C4b,2a,3b (Kim et al., 1992) . Thus it is tempting to speculate that the enclosure of the epitopecontaining hydrophobic region may play a role in locking the functional sites in the proper configuration.
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